Research & Data Reports

What our own laboratory testing records show—published as aggregate numbers, with every denominator, method, limitation and source in view.

Published by Auspicious Laboratory, Inc.
Houston Westchase testing laboratory
CLIA certified · CAP accredited

The program

What does the Auspicious Laboratory research program publish?

Auspicious Laboratory, Inc. publishes reports built from its own testing records at its Houston Westchase location, read alongside public health surveillance and CDC clinical guidance. The aim is practical: to find where result explanations, screening information and follow-up can be clearer—not to rank risk or promote a test.

Every report states its time frame and data snapshot, names the unit being counted (orders, panels, records or people), and gives numerators and denominators together, with descriptive 95% intervals for the main estimates, so that each figure can be checked and quoted in context.

Checks

How are the reports checked before they are published?

Figures are reconciled against the laboratory’s aggregate research files, and each report says what was and was not re-audited.
Methods, limitations and the laboratory’s commercial interest in the subject are published with every report.
Public sources are cited and linked; citing them does not imply their participation or endorsement. Each report states whether it has undergone journal peer review.
A medical-review line appears on a report only after that report has completed medical review; until then, the report does not claim a medical reviewer. Editorial standards are described in our medical review and editorial policy.

Privacy

Do the reports contain any patient information?

No. Reports present aggregate counts only. No names, contact details, dates of birth, addresses or individual results appear in any report, and no patient-level records are published. Situations used to explain results are educational illustrations, not real cases.

Our reports describe tested records at one location. They do not estimate how common an infection is in the community, and they are health information—not a diagnosis or a prescription.

Reports

Which research reports are available?

STI testing data · Data snapshot: 2026-09-27

West Houston STD Research Report 2025–2026

At Auspicious Laboratory’s Houston Westchase testing location (January 2025–September 27, 2026; 465 STI- or HIV-related orders), Ureaplasma urealyticum was detected in 139 of 377 valid results (36.9%) and Gardnerella vaginalis in 127 of 392 (32.4%), repeat tests included—the two most frequent detections. The report asks when a detection does or does not call for treatment, how window periods affect retesting, and whether age is associated with detection.

36.9% · UU 139/37732.4% · GV 127/39215.8% (38/241) under 35 vs 4.2% (6/144) 35+

Detection rates in one testing sample, not community prevalence; a detection is not automatically a diagnosis or a reason for treatment; age figures include repeat tests and show an exploratory association, not causation or individual risk.

Published 2026-09-28
Updated 2026-09-29 (research-focus revision)
Published by Auspicious Laboratory, Inc.
English and Chinese editions

Read the report 阅读中文版

Questions

How can I cite a report or report an error?

Each report ends with a suggested citation and its canonical URL. When quoting a figure, please keep its numerator, denominator, time frame and setting together. To ask about methods or to report an error, email info@auspiciouslab.com; our editorial policy explains how corrections are handled. Learn more about Auspicious Laboratory or read our STD and STI testing overview.

How can I reach the lab privately?

No name needed to ask a question. Text is the fastest way to reach us.

💬 Text us 📞 Call us ✉️ Email us

Or send your details below — we will reply by text or email during open hours.